TLR9 in Mitochondrial Innate Immunity, activated in several autoimmune diseases, including psoriasis, is currently under investigation as a potential therapeutic target, where TLR antagonists are being developed for the treatment of these conditions [36]. Here, TLR9 is linked to psoriasis.